{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:07:24Z","timestamp":1793398044788,"version":"4.5.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jsat.2020.108146","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T03:48:00Z","timestamp":1600746480000},"page":"108146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder"],"prefix":"10.1016","volume":"119","author":[{"given":"Katharine","family":"Cioe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanne E.","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Easly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13311-019-00814-4","article-title":"Availability of medications for the treatment of alcohol and opioid use disorder in the USA","volume":"17","author":"Abraham","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jsat.2020.108146_bb0010","unstructured":"Adminstration, S. A. a. M. H. S. (2016). Decisions in recovery: Medications for opioid use disorder. Retrieved from: Available from http:\/\/www.samhsa.gov\/brss-tacs\/shared-decision-making. (Accessed 2016)."},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/108107398127355","article-title":"Perpetuating passivity: Reliance and reciprocal determinism in physician-patient interaction","volume":"3","author":"Akoul","year":"1998","journal-title":"Journal of Health Communication"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb9005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2011.01.009","article-title":"Injection drug users' experience with and attitudes toward methadone clinics in Denver, CO","volume":"41","author":"Al-Tayyib","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108146_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2015.10.003","article-title":"Extended-release naltrexone: A qualitative analysis of barriers to routine use","volume":"62","author":"Alanis-Hirsch","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08897077.2015.1062457","article-title":"Counselor training and attitudes toward pharmacotherapies for opioid use disorder","volume":"37","author":"Aletraris","year":"2016","journal-title":"Substance Abuse"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb9010","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/10826080802483936","article-title":"Supervised methadone consumption: client issues and stigma","volume":"44","author":"Anstice","year":"2009","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ajad.12406","article-title":"Changes in psychiatry residents\u2019 attitudes towards individuals with substance use disorders over the course of residency training","volume":"26","author":"Avery","year":"2017","journal-title":"American Journal of Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02791072.2010.10400696","article-title":"Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance","volume":"42","author":"Awgu","year":"2010","journal-title":"Journal of Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11606-008-0881-9","article-title":"Integrating buprenorphine treatment into office-based practice: a qualitative study","volume":"24","author":"Barry","year":"2009","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J465v26n01_02","article-title":"Provider satisfaction with office-based treatment of opioid dependence: a systematic review","volume":"26","author":"Becker","year":"2005","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0055","first-page":"33","article-title":"Challenging perspectives on MMT","volume":"2","author":"Benton","year":"2001","journal-title":"Response. N Z Bioeth J"},{"key":"10.1016\/j.jsat.2020.108146_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2015.04.002","article-title":"Patient perspectives associated with intended duration of buprenorphine maintenance therapy","volume":"56","author":"Bentzley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108146_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: Perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108146_bb0070","doi-asserted-by":"crossref","first-page":"w13933","DOI":"10.4414\/smw.2014.13933","article-title":"Opioid maintenance therapy in Switzerland: An overview of the Swiss IMPROVE study","volume":"144","author":"Besson","year":"2014","journal-title":"Swiss Med Weekly"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2020.108146_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000052037","article-title":"The French experience\u2014The pharmacist, general practitioner and patient perspective","volume":"4","author":"Bouchez","year":"1998","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2020.108146_bb0080","unstructured":"Braeburn Pharmaceuticals. (2020). Braeburn Submits Request for Final Approval of BRIXADI\u2122 (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder. Retrieved from: https:\/\/braeburnrx.com\/braeburn-submits-request-for-final-approval-of-brixadi-buprenorphine-extended-release-injection-for-the-treatment-of-opioid-use-disorder\/. (Accessed 6\/17\/2020."},{"issue":"8","key":"10.1016\/j.jsat.2020.108146_bb0085","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/10826084.2014.888449","article-title":"Self-management of buprenorphine\/naloxone among online discussion board users","volume":"49","author":"Brown","year":"2014","journal-title":"Substance Use & Misuse"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/10826087209026777","article-title":"Staff and client attitudes toward methadone maintenance","volume":"7","author":"Brown","year":"1972","journal-title":"The International Journal of the Addictions"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/ajp.131.2.215","article-title":"Staff attitudes and conflict regarding the use of methadone in the treatment of heroin addiction","volume":"131","author":"Brown","year":"1974","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1176\/ajp.132.6.623","article-title":"Methadone maintenance: Some client opinions","volume":"132","author":"Brown","year":"1975","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb9015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/15332640.2016.1196632","article-title":"Attitudes toward medication-assisted treatment among fishermen in Kuantan, Malaysia, who inject drugs","volume":"16","author":"Brown","year":"2017","journal-title":"Journal of Ethnicity in Substance Abuse"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/10826089609045820","article-title":"Attitudes and beliefs of staff working in methadone maintenance clinics","volume":"31","author":"Caplehorn","year":"1996","journal-title":"Substance Use & Misuse"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1467-842X.1998.tb01422.x","article-title":"Changing attitudes and beliefs of staff working in methadone maintenance programs","volume":"22","author":"Caplehorn","year":"1998","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108146_bb0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug & Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990500328455","article-title":"Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians","volume":"32","author":"Coffin","year":"2006","journal-title":"American Journal of Drug & Alcohol Abuse"},{"key":"10.1016\/j.jsat.2020.108146_bb0125","article-title":"National practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"66","author":"Comer","year":"2015","journal-title":"American Society of Addicition Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"16","key":"10.1016\/j.jsat.2020.108146_bb0135","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2014Indiana, 2015","volume":"64","author":"Conrad","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0140","first-page":"336","article-title":"Attending physicians\u2019 and residents\u2019 attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital","volume":"38","author":"Cunningham","year":"2006","journal-title":"Family Medicine"},{"issue":"9","key":"10.1016\/j.jsat.2020.108146_bb0145","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11606-007-0264-7","article-title":"Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians","volume":"22","author":"Cunningham","year":"2007","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsat.2009.07.002","article-title":"Preference for buprenorphine\/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study","volume":"38","author":"Daulouede","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01254645","article-title":"Love and hate in methadone maintenance","volume":"37","author":"Davidson","year":"1977","journal-title":"American Journal of Psychoanalysis"},{"issue":"10","key":"10.1016\/j.jsat.2020.108146_bb9030","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijnurstu.2011.03.009","article-title":"A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals","volume":"48","author":"De Maeyer","year":"2011","journal-title":"International Journal of Nursing Studies"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1522-8649(07)50035-1","article-title":"The early history of methadone. Myths and facts","volume":"25","author":"Defalque","year":"2007","journal-title":"Bulletin of Anesthesia History"},{"key":"10.1016\/j.jsat.2020.108146_bb9035","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural and Remote Health"},{"issue":"19","key":"10.1016\/j.jsat.2020.108146_bb0165","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/jama.1976.03260450029025","article-title":"Methadone maintenance treatment. A ten-year perspective","volume":"235","author":"Dole","year":"1976","journal-title":"Jama"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2020.108146_bb0170","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/QAI.0b013e3182097561","article-title":"Patient perspectives on buprenorphine\/naloxone treatment in the context of HIV care","volume":"56","author":"Egan","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213644","article-title":"The views of patients, healthcare professionals and hospital officials on barriers to and facilitators of quality pain management in Ethiopian hospitals: A qualitative study","volume":"14","author":"Eshete","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamapsychiatry.2018.3685","article-title":"Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X waiver","volume":"76","author":"Fiscella","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2020.108146_bb0185","unstructured":"Fischer, B., Cape, D., Daniel, N., & Gliksman, L. (2002a). Methadone treatment in Ontario after the 1996 regulation reforms. Results of a physician survey. Annals de Medecine Interne (Paris), 153(7 Suppl), 2S11\u201321."},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1081\/JA-120002807","article-title":"Canadian illicit opiate users\u2019 views on methadone and other opiate prescription treatment: An exploratory qualitative study","volume":"37","author":"Fischer","year":"2002","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2020.108146_bb0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2015.1088496","article-title":"Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients\u2019 experiences and preferences","volume":"37","author":"Fox","year":"2016","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/13814788.2015.1120286","article-title":"How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium","volume":"22","author":"Fraeyman","year":"2016","journal-title":"European Journal of General Practice"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0740-5472(89)90039-1","article-title":"Naltrexone treatment\u2014the problem of patient acceptance","volume":"6","author":"Fram","year":"1989","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10826084.2017.1310247","article-title":"\u201cI was not sick and I didn\u2019t need to recover\u201d: Methadone maintenance treatment (MMT) as a refuge from criminalization","volume":"53","author":"Frank","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145817","article-title":"Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature","volume":"11","author":"Friedrichs","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10550887.2014.950030","article-title":"Diffusion and diversion of suboxone: An exploration of illicit street opioid selling","volume":"33","author":"Furst","year":"2014","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugpo.2014.10.002","article-title":"An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia","volume":"26","author":"Ghani","year":"2015","journal-title":"The International Journal on Drug Policy"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0235","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/09595230701499118","article-title":"Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff","volume":"26","author":"Gjersing","year":"2007","journal-title":"Drug & Alcohol Review"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0740-5472(88)90037-2","article-title":"Tapering from methadone maintenance: Attitudes of clients and staff","volume":"5","author":"Gold","year":"1988","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0245","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/10826084.2012.644117","article-title":"In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment","volume":"47","author":"Golovanevskaya","year":"2012","journal-title":"Substance Use & Misuse"},{"issue":"12","key":"10.1016\/j.jsat.2020.108146_bb0250","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1080\/10826080500259497","article-title":"Users' experiences of heroin and methadone treatment","volume":"40","author":"Gourlay","year":"2005","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"American Journal of Addictions"},{"issue":"9","key":"10.1016\/j.jsat.2020.108146_bb0260","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1360-0443.2012.03859.x","article-title":"Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China","volume":"107","author":"Gu","year":"2012","journal-title":"Addiction"},{"issue":"14","key":"10.1016\/j.jsat.2020.108146_bb0265","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3109\/10826080802494800","article-title":"Methadone maintenance treatment for youth: Experiences of clients, staff, and parents","volume":"44","author":"Guarino","year":"2009","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2020.108146_bb0270","first-page":"70","article-title":"Naltrexone in methadone maintenance patients electing to become \u201cdrug free\u201d","volume":"9","author":"Haas","year":"1976","journal-title":"NIDA Research Monograph"},{"key":"10.1016\/j.jsat.2020.108146_bb0275","doi-asserted-by":"crossref","unstructured":"Haffajee, R. L., Bohnert, A. S. B., & Lagisetty, P. A. (2018). Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment. American Journal of Preventive Medicine, 54(6, Supplement 3), S230\u2013S242.","DOI":"10.1016\/j.amepre.2017.12.022"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10826084.2017.1385633","article-title":"At the expense of a life: Race, class, and the meaning of buprenorphine in pharmaceuticalized \u201ccare\u201d","volume":"53","author":"Hatcher","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0285","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11469-009-9204-6","article-title":"Access to care for methadone maintenance patients in the United States","volume":"7","author":"Hettema","year":"2009","journal-title":"International Journal of Mental Health and Addiction"},{"key":"10.1016\/j.jsat.2020.108146_bb0290","doi-asserted-by":"crossref","unstructured":"Hewell, V. M., Vasquez, A. R., & Rivkin, I. D. (2017). Systemic and individual factors in the buprenorphine treatment-seeking process: A qualitative study. Substance Abuse Treatment, Prevention, and Policy, 12(1), 3.","DOI":"10.1186\/s13011-016-0085-y"},{"key":"10.1016\/j.jsat.2020.108146_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11\u221212","key":"10.1016\/j.jsat.2020.108146_bb0300","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3109\/10826088509047261","article-title":"\u201cIt takes your heart\u201d: The image of methadone maintenance in the addict world and its effect on recruitment into treatment","volume":"20","author":"Hunt","year":"1985","journal-title":"International Journal of the Addictions"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.jsat.2020.108146_bb0310","series-title":"Sublocade, prescribing information","author":"Indivior","year":"2017"},{"key":"10.1016\/j.jsat.2020.108146_bb9040","first-page":"767","article-title":"Attitudes and beliefs of clients toward methadone prior to and during treatment","volume":"1","author":"Jansen","year":"1973","journal-title":"Proceedings. National Conference on Methadone Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0315","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.2014.960109","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective","volume":"46","author":"Johnson","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2020.108146_bb0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2015.01.013","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: The importance of patients\u2019 attitudes and norms","volume":"54","author":"Johnson","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0325","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2006.10399832","article-title":"Predicting treatment retention with a brief \u201cOpinions About Methadone\u201d scale","volume":"38","author":"Kayman","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb9045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00952990.2011.643983","article-title":"A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients","volume":"38","author":"Kelly","year":"2012","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb9050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12939-018-0787-z","article-title":"Perceived barriers to methadone maintenance treatment among Iranian opioid users","volume":"17","author":"Khazaee-Pool","year":"2018","journal-title":"International Journal for Equity in Health"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1300\/J069v25n04_09","article-title":"Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence","volume":"25","author":"Kissin","year":"2006","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2020.108146_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugpo.2017.01.015","article-title":"The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective","volume":"43","author":"Klingemann","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.jsat.2020.108146_bb0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/adaw.32270","article-title":"Sublocade trial data published: Better than placebo","volume":"31","author":"Knopf","year":"2019","journal-title":"Alcoholism & Drug Abuse Weekly"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2005.05.002","article-title":"Buprenorphine diffusion: The attitudes of substance abuse treatment counselors","volume":"29","author":"Knudsen","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"14","key":"10.1016\/j.jsat.2020.108146_bb9055","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3109\/10826089909039442","article-title":"Active heroin injectors' perceptions and use of methadone maintenance treatment: cynical performance or self-prescribed risk reduction?","volume":"34","author":"Koester","year":"1999","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0355","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08897077.2015.1129388","article-title":"Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders","volume":"37","author":"Komaromy","year":"2016","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0360","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care\u2013based models for the treatment of opioid use disorder: A scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2020.108146_bb0365","first-page":"S1","article-title":"Buprenorphine for office-based practice: Consensus conference overview","volume":"13","author":"Kosten","year":"2004","journal-title":"American Journal of Addictions"},{"key":"10.1016\/j.jsat.2020.108146_bb0370","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts Collaborative Care Model in Community Health Centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0375","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03166918","article-title":"Methadone maintenance in general practice: Impact on staff attitudes","volume":"169","author":"Langton","year":"2000","journal-title":"Irish Journal of Medical Science"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0380","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1465-3362.2010.00274.x","article-title":"Prescribers\u2019 perceptions of the diversion and injection of medication by opioid substitution treatment patients","volume":"30","author":"Larance","year":"2011","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0385","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/dar.12442","article-title":"A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia","volume":"36","author":"Larney","year":"2017","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10118","key":"10.1016\/j.jsat.2020.108146_bb0395","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1753-6405.2001.tb01832.x","article-title":"Withdrawal from methadone maintenance treatment: Prognosis and participant perspectives","volume":"25","author":"Lenne","year":"2001","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108146_bb9065","first-page":"99","article-title":"Use of narcotic antagonists (naltrexone) in an addiction treatment program","author":"Lewis","year":"1976","journal-title":"NIDA Research Monograph(9)"},{"issue":"9","key":"10.1016\/j.jsat.2020.108146_bb9070","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3109\/10826084.2011.561905","article-title":"Opiate users' perceived barriers against attending methadone maintenance therapy: a qualitative study in China","volume":"46","author":"Lin","year":"2011","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2020.108146_bb9075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2018.01.015","article-title":"Perceptions and practices addressing diversion among US buprenorphine prescribers","volume":"186","author":"Lin","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0405","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/10826084.2017.1310248","article-title":"Commune health Workers\u2019 methadone maintenance treatment (MMT) knowledge and perceived difficulties providing decentralized MMT services in Vietnam","volume":"53","author":"Lin","year":"2018","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2020.108146_bb9080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1747-597X-8-29","article-title":"Assessment of attitudes towards methadone maintenance treatment between heroin users at a compulsory detoxification centre and methadone maintenance clinic in Ningbo, China","volume":"8","author":"Liu","year":"2013","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0410","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","article-title":"The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review","volume":"107","author":"Livingston","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0415","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10826084.2017.1325376","article-title":"Primary care physicians\u2019 views about prescribing methadone to treat opioid use disorder","volume":"53","author":"Livingston","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0420","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1755-5949.2010.00194.x","article-title":"Naltrexone depot formulations for opioid and alcohol dependence: A systematic review","volume":"17","author":"Lobmaier","year":"2011","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/ADM.0000000000000029","article-title":"Buprenorphine diversion and misuse in outpatient practice","volume":"8","author":"Lofwall","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0435","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12875-019-1047-z","article-title":"Attitudes of primary care physicians toward prescribing buprenorphine: A narrative review","volume":"20","author":"Louie","year":"2019","journal-title":"BMC Family Practice"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0440","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1370\/afm.2103","article-title":"Medication-assisted treatment should be part of every family physician\u2019s practice: Yes","volume":"15","author":"Loxterkamp","year":"2017","journal-title":"Annals of Family Medicine"},{"issue":"11","key":"10.1016\/j.jsat.2020.108146_bb0445","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s40267-013-0079-z","article-title":"Buprenorphine\/naloxone sublingual tablet (Zubsolv\u00ae): A guide to its use in the maintenance treatment of opioid dependence in the USA","volume":"29","author":"Lyseng-Williamson","year":"2013","journal-title":"Drugs & Therapy Perspectives"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0450","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/09595230801935706","article-title":"Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment","volume":"27","author":"Madden","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2020.108146_bb9090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2016.06.011","article-title":"Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","volume":"165","author":"Makarenko","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108146_bb9095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsat.2015.11.004","article-title":"\"I Kicked the Hard Way. I Got Incarcerated.\" Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments","volume":"62","author":"Maradiaga","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0455","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/ADM.0000000000000145","article-title":"The role of gender in factors associated with addiction treatment satisfaction among long-term opioid users","volume":"9","author":"Marchand","year":"2015","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2020.108146_bb0460","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2017.07.010","article-title":"Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine","volume":"179","author":"Marcus","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108146_bb0465","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsat.2018.01.003","article-title":"A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine","volume":"86","author":"Marcus","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0470","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/ajad.12550","article-title":"Access to treatment for opioid use disorders: Medical student preparation","volume":"26","author":"McCance-Katz","year":"2017","journal-title":"American Journal of Addictions"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0475","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/M19-3975","article-title":"Medication for opioid use disorder: A national survey of primary care physicians","volume":"173","author":"McGinty","year":"2020","journal-title":"Annals of Internal Medicine."},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0480","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5993\/AJHB.30.5.11","article-title":"Clinic-based treatment for opioid dependence: A qualitative inquiry","volume":"30","author":"McMurphy","year":"2006","journal-title":"American Journal of Health Behavior"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0485","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02350965","article-title":"Office-based methadone prescribing: Acceptance by inner-city practitioners in New York","volume":"77","author":"McNeely","year":"2000","journal-title":"Journal of Urban Health"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0490","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1363461516660884","article-title":"Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America","volume":"53","author":"Mendoza","year":"2016","journal-title":"Transcultural Psychiatry"},{"key":"10.1016\/j.jsat.2020.108146_bb9100","first-page":"589","article-title":"Methadone maintenance outcome as a function of detoxification fear: preliminary findings","volume":"105","author":"Milby","year":"1990","journal-title":"NIDA Research Monograph"},{"key":"10.1016\/j.jsat.2020.108146_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"4","author":"Minozzi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb9105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/02791072.2009.10399907","article-title":"Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users","volume":"41","author":"Mitchell","year":"2009","journal-title":"Journal of Psychoactive Drugs"},{"issue":"10","key":"10.1016\/j.jsat.2020.108146_bb9110","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1360-0443.1998.9310156714.x","article-title":"French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphine","volume":"93","author":"Moatti","year":"1998","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0500","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2020.108146_bb9115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13011-015-0009-2","article-title":"Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio","volume":"10","author":"Molfenter","year":"2015","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2020.108146_bb0505","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention","volume":"57","author":"Monico","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb9120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1081\/JA-120002814","article-title":"Appreciating the user's perspective: listening to the \"methadonians\"","volume":"37","author":"Montagne","year":"2002","journal-title":"Substance Use & Misuse"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2020.108146_bb0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/11536040-000000000-00000","article-title":"Therapeutic switch to buprenorphine\/naloxone from buprenorphine alone: Clinical experience in an Italian addiction centre","volume":"30","author":"Montesano","year":"2010","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0515","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/JAN.0000000000000242","article-title":"A nurse practitioner\u2019s perspective on prescribing suboxone for opioid use disorder","volume":"29","author":"Moore","year":"2018","journal-title":"Journal of Addictions Nursing"},{"issue":"9","key":"10.1016\/j.jsat.2020.108146_bb0520","first-page":"583","article-title":"Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: A qualitative study in Iran","volume":"4","author":"Moradi","year":"2015","journal-title":"Internationl Journal of Health Policy and Management"},{"key":"10.1016\/j.jsat.2020.108146_bb9125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2016.04.037","article-title":"Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia","volume":"164","author":"Mukherjee","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108146_bb0525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2018.02.018","article-title":"Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications","volume":"187","author":"Muller","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0530","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1360-0443.1976.tb00077.x","article-title":"Methadone maintenance: It ain\u2019t what it used to be","volume":"71","author":"Newman","year":"1976","journal-title":"British Journal Addiction to Alcohol and Other Drugs"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0535","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/08897077.2014.941085","article-title":"Exploring the concepts of abstinence and recovery through the experiences of long-term opiate substitution clients","volume":"36","author":"Notley","year":"2015","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0540","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1353\/cpr.2007.0032","article-title":"Perceptions of methadone maintained clients about barriers and facilitators to help-seeking behavior","volume":"1","author":"Nyamathi","year":"2007","journal-title":"Progress in Community Health Partnerships"},{"key":"10.1016\/j.jsat.2020.108146_bb0545","first-page":"51","volume":"6","author":"Pelet","year":"2005","journal-title":"Difficulties associated with outpatient management of drug abusers by general practitioners. A cross-sectional survey of general practitioners with and without methadone patients in Switzerland. BMC Family Practice"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0550","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","article-title":"Why don\u2019t out-of-treatment individuals enter methadone treatment programmes?","volume":"21","author":"Peterson","year":"2010","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0555","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.jsat.2020.108146_bb0560","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s10461-016-1375-0","article-title":"Attitudes toward addiction, methadone treatment, and recovery among HIV-infected Ukrainian prisoners who inject drugs: Incarceration effects and exploration of mediators","volume":"20","author":"Polonsky","year":"2016","journal-title":"AIDS and Behavior"},{"issue":"14","key":"10.1016\/j.jsat.2020.108146_bb0565","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3109\/10826089909039434","article-title":"The street\/treatment barrier: Treatment experiences of Puerto Rican injection drug users","volume":"34","author":"Porter","year":"1999","journal-title":"Substance Use & Misuse"},{"issue":"7","key":"10.1016\/j.jsat.2020.108146_bb0570","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/10826084.2016.1155615","article-title":"Perceptions related to pharmacological treatment of opioid dependence among individuals seeking treatment at a tertiary care center in northern India: A descriptive study","volume":"51","author":"Prakash","year":"2016","journal-title":"Substance Use & Misuse"},{"issue":"7","key":"10.1016\/j.jsat.2020.108146_bb9130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMp1715093","article-title":"Caring for Ms. L. - Overcoming My Fear of Treating Opioid Use Disorder","volume":"378","author":"Provenzano","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2020.108146_bb0575","series-title":"Project ECHO trains, empowers New Mexico FPs to provide subspecialty","author":"Pupillo","year":"2016"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0580","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","article-title":"Premature discharge from methadone treatment: Patient perspectives","volume":"41","author":"Reisinger","year":"2009","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2020.108146_bb0585","first-page":"84","article-title":"A point of view concerning treatment approaches with narcotic antagonists","volume":"9","author":"Resnick","year":"1976","journal-title":"NIDA Research Monograph"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0590","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2009","journal-title":"Journal off Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0595","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsat.2006.09.002","article-title":"Client and counselor attitudes toward the use of medications for treatment of opioid dependence","volume":"32","author":"Rieckmann","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0600","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Affairs (Millwood)"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0605","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jsat.2007.05.009","article-title":"Nurse practitioner and physician assistant interest in prescribing buprenorphine","volume":"34","author":"Roose","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0610","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02791072.1991.10472571","article-title":"Ambivalence toward methadone treatment among intravenous drug users","volume":"23","author":"Rosenblum","year":"1991","journal-title":"Journal of Psychoactive Drugs"},{"issue":"13","key":"10.1016\/j.jsat.2020.108146_bb0615","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1177\/1049732317732307","article-title":"Why people who inject drugs voluntarily transition off methadone in Ukraine","volume":"27","author":"Rozanova","year":"2017","journal-title":"Qualitative and Health Research"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0620","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/ADM.0b013e318297021e","article-title":"Meaning and methadone: Patient perceptions of methadone dose and a model to promote adherence to maintenance treatment","volume":"7","author":"Sanders","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2020.108146_bb0625","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/00952997509005667","article-title":"Clinical use of naltrexone (EN 1639 A). Part II: Experience with the first 50 patients in a New York City treatment clinic","volume":"2","author":"Schecter","year":"1975","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"5152","key":"10.1016\/j.jsat.2020.108146_bb0630","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths - United States, 2013-2017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0635","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1521-0391.2013.12024.x","article-title":"Clinician beliefs and attitudes about buprenorphine\/naloxone diversion","volume":"22","author":"Schuman-Olivier","year":"2013","journal-title":"American Journal of Addiction"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0640","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"American Journal of Addiction"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0645","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5055\/jom.2013.0183","article-title":"Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program","volume":"9","author":"Shah","year":"2013","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb9145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/10550887.2016.1235404","article-title":"Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel","volume":"36","author":"Shidlansik","year":"2017","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0650","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/00952998409002781","article-title":"The index of choice: Indications of methadone patients\u2019 selection of naltrexone treatment","volume":"10","author":"Singleton","year":"1984","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0655","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5055\/jom.2013.0152","article-title":"Consumer attitudes about opioid addiction treatment: A focus group study in New York City","volume":"9","author":"Sohler","year":"2013","journal-title":"Journal of Opioid Management"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb0660","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/JCP.0b013e31822cd446","article-title":"Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: Results from a nationally representative cohort study","volume":"31","author":"Soyka","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"14","key":"10.1016\/j.jsat.2020.108146_bb0665","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.2019.0834","article-title":"Nurse practitioner and physician assistant waivers to prescribe buprenorphine and state scope of practice restrictions","volume":"321","author":"Spetz","year":"2019","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb9150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5055\/jom.2008.0012","article-title":"A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners","volume":"4","author":"Springer","year":"2008","journal-title":"Journal of Opioid Management"},{"issue":"4","key":"10.1016\/j.jsat.2020.108146_bb0670","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jurban\/79.4.571","article-title":"Beliefs about methadone in an inner-city methadone clinic","volume":"79","author":"Stancliff","year":"2002","journal-title":"Journal of Urban Health"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0675","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/1355621031000069873","article-title":"User views on supervised methadone consumption","volume":"8","author":"Stone","year":"2003","journal-title":"Addiction Biology"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0680","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10826087409057353","article-title":"Addict attitudes toward methadone maintenance: A preliminary report","volume":"9","author":"Sutker","year":"1974","journal-title":"International Journal of Addiction"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb0685","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1521-0391.2014.12143.x","article-title":"Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency","volume":"23","author":"Suzuki","year":"2014","journal-title":"American Journal of Addiction"},{"issue":"12","key":"10.1016\/j.jsat.2020.108146_bb0690","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: A randomized clinical noninferiority trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb9155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02791072.2014.921743","article-title":"Patient perspectives on buprenorphine\/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study","volume":"46","author":"Teruya","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"8","key":"10.1016\/j.jsat.2020.108146_bb9160","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/ps.2008.59.8.909","article-title":"Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists","volume":"59","author":"Thomas","year":"2008","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2020.108146_bb0695","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients\u2019 beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0700","first-page":"23","article-title":"Suboxone: Rationale, science, misconceptions","volume":"18","author":"Velander","year":"2018","journal-title":"Ochsner Journal"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0705","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108146_bb0710","series-title":"Narcotics anonymous and the pharmacotherapeutic treatment of opioid addiction in the United States","author":"White","year":"2011"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2020.108146_bb0715","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2009.03.008","article-title":"Open-label dose-finding trial of buprenorphine implants (Probuphine)\u00ae for treatment of heroin dependence","volume":"103","author":"White","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.jsat.2020.108146_bb9165","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1465-3362.2009.00127.x","article-title":"Why do patients report transferring between methadone and buprenorphine?","volume":"28","author":"Winstock","year":"2009","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2020.108146_bb0720","article-title":"\u201cDon\u2019t judge a book by its cover\u201d: A qualitative study of methadone patients\u2019 experiences of stigma","volume":"11","author":"Woo","year":"2017","journal-title":"Substance Abuse: Research and Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0725","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: Findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0730","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/pubmed\/fds079","article-title":"Methadone maintenance treatment in China: Perceived challenges from the perspectives of service providers and patients","volume":"35","author":"Wu","year":"2013","journal-title":"Journal of Public Health (Oxford)"},{"key":"10.1016\/j.jsat.2020.108146_bb0735","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb9170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.addbeh.2012.01.020","article-title":"Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China","volume":"37","author":"Xu","year":"2012","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2020.108146_bb0740","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108146_bb0745","doi-asserted-by":"crossref","unstructured":"A Yokell, M., D Zaller, N., C Green, T., & D Rich, J. (2011). Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review. Current Drug Abuse Reviews, 4(1), 28\u201341.","DOI":"10.2174\/1874473711104010028"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0750","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijerph6020787","article-title":"Attitudes toward methadone among out-of-treatment minority injection drug users: Implications for health disparities","volume":"6","author":"Zaller","year":"2009","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0755","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugpo.2009.03.001","article-title":"A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran","volume":"21","author":"Zamani","year":"2010","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2020.108146_bb0760","doi-asserted-by":"crossref","unstructured":"Zerbo, E., Traba, C., Matthew, P., Chen, S., Holland, B. K., Levounis, P., . . . Lamba, S. (2020). DATA 2000 waiver training for medical students: Lessons learned from a medical school experience. Substance Abuse, 1\u20135.","DOI":"10.1080\/08897077.2019.1692323"},{"issue":"2","key":"10.1016\/j.jsat.2020.108146_bb0765","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.jsat.2020.108146_bb0770","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/02791072.1998.10399674","article-title":"Attitudes toward methadone maintenance: Implications for HIV prevention","volume":"30","author":"Zule","year":"1998","journal-title":"Journal of Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.jsat.2020.108146_bb9180","first-page":"588","article-title":"Methadone maintenance in the treatment of opioid dependence. A current perspective","volume":"152","author":"Zweben","year":"1990","journal-title":"The Western Journal of Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2020.108146_bb0775","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02791072.1988.10472498","article-title":"Misunderstandings about methadone","volume":"20","author":"Zweben","year":"1988","journal-title":"Journal of Psychoactive Drugs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:04Z","timestamp":1760039584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220304037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":183,"alternative-id":["S0740547220304037"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108146","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108146"}}